Price Increase For TB Drug Reversed After Turing Controversy
Turing Pharmaceuticals found itself in hot water after it raised the price of an important drug. And it looks like other companies took the hint.By Briana Altergott | September 21, 2015
Turing Pharmaceuticals suddenly found itself one of America's most hated companies after it raised the price of an important drug by more than 4,000 percent. And it looks like other pharma companies took the hint.
According to The New York Times, Rodelis Therapeutics, the company that recently acquired the tuberculosis drug cycloserine, reversed its huge overnight price increase of the drug on Monday.
The outlet claims Rodelis gave cycloserine back to its previous owner, a nonprofit organization affiliated with Purdue University, after that organization suspected the drug was being unjustly overpriced.